SM
LRMR icon

Sabby Management’s Larimar Therapeutics LRMR Stock Holding History

Sabby Management’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12
Closed -$69K – 239
2017
Q1 		$69K Buy
+12
New +$596 ﹤0.01% 242
2016
Q4 		– Sell
-179
Closed -$15K – 314
2016
Q3 		$15K Buy
179
+101
+129% +$4.59K ﹤0.01% 307
2016
Q2 		$557K Sell
78
-43
-36% -$3.4K 0.03% 208
2016
Q1 		$966K Buy
121
+39
+48% +$3.08K 0.05% 157
2015
Q4 		$617K Buy
82
+2
+3% +$321 0.03% 222
2015
Q3 		$3.07M Buy
80
+71
+789% +$32K 0.13% 124
2015
Q2 		$381K Buy
+9
New +$3.77K 0.01% 268

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return